2-106413119-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The ENST00000409886.4(RGPD3):āc.5231T>Cā(p.Leu1744Pro) variant causes a missense change. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.0026 ( 0 hom., cov: 29)
Exomes š: 0.0025 ( 164 hom. )
Failed GnomAD Quality Control
Consequence
RGPD3
ENST00000409886.4 missense
ENST00000409886.4 missense
Scores
1
18
Clinical Significance
Conservation
PhyloP100: 5.67
Genes affected
RGPD3 (HGNC:32416): (RANBP2 like and GRIP domain containing 3) This gene is located in a cluster of Ran-binding protein related genes on chromosome 2 which arose through duplication in primates. The encoded protein contains an N-terminal TPR (tetratricopeptide repeat) domain, two Ran-binding domains, and a C-terminal GRIP domain (golgin-97, RanBP2alpha, Imh1p and p230/golgin-245) domain. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0046307743).
BP6
Variant 2-106413119-A-G is Benign according to our data. Variant chr2-106413119-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 2360286.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGPD3 | NM_001144013.2 | c.5231T>C | p.Leu1744Pro | missense_variant | 22/23 | ENST00000409886.4 | NP_001137485.1 | |
RGPD3 | XM_017004738.2 | c.5255T>C | p.Leu1752Pro | missense_variant | 23/24 | XP_016860227.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGPD3 | ENST00000409886.4 | c.5231T>C | p.Leu1744Pro | missense_variant | 22/23 | 1 | NM_001144013.2 | ENSP00000386588.4 | ||
RGPD3 | ENST00000304514.11 | c.5213T>C | p.Leu1738Pro | missense_variant | 22/23 | 2 | ENSP00000303659.8 |
Frequencies
GnomAD3 genomes AF: 0.00266 AC: 398AN: 149848Hom.: 0 Cov.: 29
GnomAD3 genomes
AF:
AC:
398
AN:
149848
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00301 AC: 749AN: 249134Hom.: 12 AF XY: 0.00311 AC XY: 420AN XY: 134984
GnomAD3 exomes
AF:
AC:
749
AN:
249134
Hom.:
AF XY:
AC XY:
420
AN XY:
134984
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00248 AC: 3589AN: 1449766Hom.: 164 Cov.: 31 AF XY: 0.00300 AC XY: 2161AN XY: 720504
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
3589
AN:
1449766
Hom.:
Cov.:
31
AF XY:
AC XY:
2161
AN XY:
720504
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00263 AC: 395AN: 149958Hom.: 0 Cov.: 29 AF XY: 0.00275 AC XY: 201AN XY: 73212
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
395
AN:
149958
Hom.:
Cov.:
29
AF XY:
AC XY:
201
AN XY:
73212
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 16, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N
REVEL
Benign
Sift
Benign
.;T
Sift4G
Benign
T;T
Polyphen
0.0
.;B
Vest4
MutPred
0.44
.;Gain of glycosylation at L1744 (P = 0.0146);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at